Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Viral Infections

Cytomegalovirus viral load monitoring after allogeneic bone marrow transplantation in patients receiving antiviral prophylaxis

Bone Marrow Transplantation volume 32, pages 795–800 (2003)Cite this article

Summary:

Cytomegalovirus viral load measurement is a powerful new tool for monitoring of CMV disease; however, the optimal strategy for use is unknown. Weekly plasma CMV viral loads and CMV-related outcomes were monitored in 46 consecutive allogeneic bone marrow transplantation (BMT) recipients receiving standardised antiviral prophylaxis. A total of 412 CMV viral loads were quantitated in the first 100 days post transplantation with 77 positive samples (19%) in 20 patients (43%). No patient with all negative CMV viral load results developed CMV disease. Two of three patients with highly positive CMV viral loads (first positive ⩽30 days post transplant, maximum viral load ⩾5000 copies/ml, and ⩾50% of samples positive) developed CMV disease. A total of 17 patients with positive CMV viral loads, who did not meet the criteria for highly positive, did not develop CMV disease. CMV viral load detection was higher in recipients who were CMV sero-positive. In conclusion, CMV disease did not occur in the setting of a persistently negative CMV viral load. A positive CMV viral load result occurred commonly after allogeneic BMT, even in patients receiving antiviral prophylaxis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Einsele H, Hebart H . Cytomegalovirus infection following stem cell transplantation. Haematologica 1999; 84 (Suppl. EHA-4): 46–49.

    PubMed  Google Scholar 

  2. Enright H, Haake R, Weisdorf D et al. Cytomegalovirus pneumonia after bone marrow transplantation. Risk factors and response to therapy. Transplantation 1993; 55: 1339–1346.

    Article  CAS  PubMed  Google Scholar 

  3. Miller W, Flynn P, McCullough J et al. Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease. Blood 1986; 67: 1162–1167.

    CAS  PubMed  Google Scholar 

  4. Machida U, Kami M, Fukui T et al. Real-time automated PCR for early diagnosis and monitoring of cytomegalovirus infection after bone marrow transplantation. J Clin Microbiol 2000; 38: 2536–2542.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Gor D, Sabin C, Prentice HG et al. Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient sero-status, acute GVHD and CMV disease. Bone Marrow Transplant 1998; 21: 597–605.

    Article  CAS  PubMed  Google Scholar 

  6. Emery VC, Sabin CA, Cope AV et al. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 2000; 355: 2032–2036.

    Article  CAS  PubMed  Google Scholar 

  7. Qamruddin AO, Oppenheim BA, Guiver M et al. Screening for cytomegalovirus (CMV) infection in allogeneic bone marrow transplantation using a quantitative whole blood polymerase chain reaction (PCR) method: analysis of potential risk factors for CMV infection. Bone Marrow Transplant 2001; 27: 301–306.

    Article  CAS  PubMed  Google Scholar 

  8. Boeckh M . Current antiviral strategies for controlling cytomegalovirus in hematopoietic stem cell transplant recipients: prevention and therapy. Transplant Infect Dis 1999; 1: 165–178.

    Article  CAS  Google Scholar 

  9. Przepiorka D, Weisdorf D, Martin P et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825–828.

    CAS  PubMed  Google Scholar 

  10. Ljungman P, Plotkin SA . Workshop of CMV disease: definitions, clinical severity scores and syndromes. Scand J Infect Dis-Suppl 1995; 99: 87–89.

    Google Scholar 

  11. Humar A, O'Rourke K, Lipton J et al. The clinical utility of CMV surveillance cultures and antigenemia following bone marrow transplantation. Bone Marrow Transplant 1999; 23: 45–51.

    Article  CAS  PubMed  Google Scholar 

  12. Ljungman P, Aschan J, Lewensohn-Fuchs I et al. Results of different strategies for reducing cytomegalovirus-associated mortality in allogeneic stem cell transplant recipients. Transplantation 1998; 66: 1330–1334.

    Article  CAS  PubMed  Google Scholar 

  13. Michaelides A, Liolios L, Glare EM et al. Increased human cytomegalovirus (HCMV) DNA load in peripheral blood leukocytes after lung transplantation correlates with HCMV pneumonitis. Transplantation 2001; 72: 141–147.

    Article  CAS  PubMed  Google Scholar 

  14. Grob JP, Grundy JE, Prentice HG et al. Immune donors can protect marrow transplant recipients from severe cytomegalovirus infections. Lancet 1987; 1: 774–776.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Infectious Diseases, Alfred Hospital, Commercial Rd., Prahran, Victoria, 3181, Melbourne, Australia

    B P Howden, D W Spelman & S Wesselingh

  2. Department of Microbiology, Alfred Hospital, Commercial Rd., Prahran, Victoria, 3181, Melbourne, Australia

    A Michaelides & D W Spelman

  3. Bone Marrow Transplant Programme, Alfred Hospital, Commercial Rd., Prahran, Victoria, 3181, Melbourne, Australia

    A Spencer & A P Schwarer

  4. Department of Respiratory Medicine, Alfred Hospital, Commercial Rd., Prahran, Victoria, 3181, Melbourne, Australia

    T C Kotsimbos

Authors
  1. B P Howden
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Michaelides
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D W Spelman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A Spencer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A P Schwarer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S Wesselingh
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. T C Kotsimbos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B P Howden.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Howden, B., Michaelides, A., Spelman, D. et al. Cytomegalovirus viral load monitoring after allogeneic bone marrow transplantation in patients receiving antiviral prophylaxis. Bone Marrow Transplant 32, 795–800 (2003). https://doi.org/10.1038/sj.bmt.1704230

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704230

Keywords

This article is cited by

Search

Advanced search

Quick links